Aerobiotix™ Expands Senior Management Team and Enters New Market Segments

September 20, 2016

LAS VEGAS–(BUSINESS WIRE)–Aerobiotix, Inc., an emerging leader in the development of novel technologies for indoor air quality (IAQ), announces the appointment of Daniel Abromowitz as VP of Sales and Marketing. Mr. Abromowitz is an established leader in building sales and marketing infrastructure in the medical device and pharmaceutical industries. Most recently, he was VP of Sales for Xtant Medical (NYSE: XTNT), and prior to that he was VP of Sales for X-spine Systems, Inc. Mr. Abromowitz is tasked with building penetration in targeted segments of healthcare, home care, and HVAC markets.

Aerobiotix™ is embarking on an aggressive product expansion plan to introduce five new product offerings within the next twelve months to address critical needs in healthcare and whole-home IAQ markets. Aerobiotix™ recently expanded its home care line of products with the launch of the AeroCure™ DNA Dust and Allergy air purifier. Designed to fight home or office dust and allergens, these units continue Aerobiotix’s standard of high-end IAQ products manufactured in the USA. This product joins the AeroCure™ by Aerobiotix™ line of high-end home air purification systems, and the Tower One line of healthcare air disinfection systems used in leading hospitals.

Privately-held Aerobiotix, Inc. is dedicated to developing, manufacturing and marketing global solutions for air quality in healthcare, home care, and HVAC markets. Aerobiotix will be showcasing its technologies at the upcoming industry tradeshows: Operating Room Manager Conference in Las Vegas, NV, September 21-23, 2016 at booth 1033 and Association for the Healthcare Environment Conference in Pittsburgh, PA, September 25-28, 2016 at booth 733.


Aerobiotix, Inc.
Daniel Abromowitz, 937-422-8405
VP of Sales and Marketing

Businessman William Parfet resigns from Stryker Corp. Board of Directors

By Al Jones – September 2, 2016

KALAMAZOO, MI – William U. Parfet unceremoniously resigned Wednesday from the Stryker Corp. Board of Directors and the company is not saying why.

Parfet, 69, was among the longest-tenured members of the board, which works on behalf of company stockholders to establish corporate policies, to provide oversight and guidance to the company’s top management, and to make decisions on major corporate issues. Parfet joined the board in 1993.

“On Aug. 31, 2016, William Parfet resigned as a director of Stryker Corp. effective immediately,” the Kalamazoo-based company stated in an email response to questions about the resignation.

Asked why he was resigning, Jenny Braga, senior manager of communications for Stryker, stated in an email that the company had no further comments on the matter.

The board continues with eight members.

In a regulatory filing, Monsanto Co. stated that Parfet also resigned Wednesday from that company’s board. Monsanto is a Missouri-based provider of agricultural products intended to improve farm productivity.

The St. Louis Post Dispatch reported online that Monsanto disclosed Parfet’s resignation in a regulatory filing but did not give a reason for his departure. Parfet had been a member of that board for 16 years.